A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I

Cancer Research

Volumn 59, Issue 11, 1999, Pages 2701-2708

  Komatani, Hideya ^a   Morita, Masashi ^a   Sakaizumi, Nami ^a   Fukasawa, Kazuhiro ^a   Yoshida, Eisaku ^a   Okura, Akira ^a   Yoshinari, Tomoko ^a   Nishimura, Susumu ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A][PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; CAMPTOTHECIN; CISPLATIN; DNA TOPOISOMERASE; DOXORUBICIN; ETOPOSIDE; IRINOTECAN; REBECCAMYCIN; TOPOTECAN;

ANIMAL CELL; ARTICLE; CROSS RESISTANCE; DRUG SENSITIVITY; GENE DUPLICATION; GENETIC LINKAGE; IMMUNOBLOTTING; LEUKEMIA P 388; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033152167     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wang, J. C. DNA topoisomerases. Annu. Rev. Biochem., 65: 635-692, 1996.
2. Stewart, L., Ireton, G. C., and Champoux, J. J. The domain organization of human topoisomerase. I. J. Biol. Chem., 271: 7602-7608, 1996.
3. Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J., and Hol, W. G. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science (Washington DC), 279: 1504-1513, 1998.
4. Stewart, A. F., and Schutz, G. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene. Cell, 50: 1109-1117, 1987.
5. Zhang, H., Wang, J. C., and Liu, L. F. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. USA. 85: 1060-1064, 1988.
6. Chen, A. Y., and Liu, L. F. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol., 94: 194-218, 1994.
7. Hsiang, Y. H., Hertzberg, R., Hecht, S., and Liu, L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 260: 14873-14878, 1985.
8. Hsiang, Y. H., and Liu, L. F. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res., 48: 1722-1726, 1988.
9. Svejstrup, J. Q., Christiansen, K., Gromova, I. I., Andersen, A. H., and Westgaard, O. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. J. Mol. Biol., 222: 669-678, 1991.
10. Hertzberg, R. P., Caranfa, M. J., and Hecht, S. M. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry, 28: 4629-4638, 1989.
11. Hsiang, Y. H., Lihou, M. G., and Liu, L. F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res., 49: 5077-5082, 1989.
12. Holm, C., Covey, J. M., Kerrigan, D., and Pommier, Y. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res., 49: 6365-6368, 1989.
13. Zhang, H., D'Arpa, P., and Liu, L. F. A model for tumor cell killing by topoisomerase poisons. Cancer Cells, 2; 23-27, 1990.
14. Wang, H. K., Morris-Natschke, S. L., and Lee, K. H. Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents. Med Res. Rev., 17: 367-425, 1997.
15. Yoshinari, T., Matsumoto, M., Arakawa, H., Okada, H., Noguchi, K., Suda, H., Okura, A., and Nishimura, S. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H- indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity. Cancer Res., 55: 1310-1315, 1995.
16. Arakawa, H., Iguchi, T., Monta, M., Yoshinari, T., Kojiri, K., Suda, H., Okura, A., and Nishimura, S. Novel indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H- indolo[2,3-a]pyrrolo-[3,4-c]carbazole-5,7(6H)-dione (NB-506): its potent antitumor activities in mice. Cancer Res., 55: 1316-1320, 1995.
17. Arakawa, H., Matsumoto, H., Monta, M., Sasaki, M., Taguchi, K., Okura, A., and Nishimura, S. Antimetastatic effect of a novel indolocarbazole (NB-506) on IMC-HM murine tumor cells metastasized to the liver. Jpn. J. Cancer Res., 87: 518-523, 1996.
18. Sugimoto, Y., Tsukahara, S., Oh-hara, T., Isoe, T., and Tsuruo, T. Decreased expressed of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res., 50: 6925-6930, 1990.
19. Eng. W. K., McCabe, F. L., Tan, K. B., Mattern, M. R., Hofmann, G. A., Woessner, R. D., Hertzberg, R. P., and Johnson, R. K. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. Mol. Pharmacol., 38: 471-480, 1990.
20. Tamura, H., Kohchi, C., Yamada, R., Ikeda, T., Koiwai, O., Patterson, E., Keene, J. D. Okada, K., Kjeldsen, E., Nishikawa, K., and Andoh, T. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Nucleic Acids Res., 19: 69-75, 1991.
21. Tanizawa, A., Bertrand, R., Kohlhagen, G., Tabuchi, A., Jenkins, J., and Pommier, Y. Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance. J. Biol Chem., 265: 25463-25468, 1993.
22. Rubin, E., Pantazis, P., Bharti, A., Toppmeyer, D., Giovanella, B., and Kufe, D. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. J. Biol. Chem., 269: 2433-2439, 1994.
23. Fujimori, A., Harker, W. G., Kohlhagen, G., Hoki, Y., and Pommier, Y. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res., 55: 1339-1346, 1995.
24. Wang, L. F., Ting, C. Y., Lo, C. K., Su, J. S. Mickley, L. A., Fojo, A. T., Whang-Peng, J., and Hwang, J. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance. Cancer Res., 57: 1516-1522, 1997.
25. Tan, K. B., Mattern, M. R., Eng, W. K., McCabe, F. L., and Johnson, R. K. Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors. J. Natl. Cancer Inst., 81: 1732-1735, 1989.
26. Madelaine, I., Prost, S., Naudin, A., Riou, G., Lavelle, F., and Riou, J. F. Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation. Biochem. Pharmacol., 45: 339-348, 1993.
27. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D., and Boyd, M. R. Evaluation of a soluble tetrazolium/ formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 48: 4827-4833, 1988.
28. Yoshinari, T., Yamada, A., Uemura, D., Normura, K., Arakawa, H., Kojiri, K., Yoshida, E., Suda, H., and Okura, A. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110. Cancer Res., 53: 490-494, 1993.
29. Deffie, A. M., Batra, J. K., and Goldenberg, G. J. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. Cancer Res., 49: 58-62, 1989.
30. Liu, L. F., and Miller, K. G. Eukaryotic DNA topoisomerases. Two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc. Natl. Acad. Sci. USA, 78: 3487-3491, 1981.
31. Koiwai, O., Yasui, Y., Sakai, Y., Watanabe, T., Ishii, K., Yanagihara, S., and Andoh, T. Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the gene. Gene, 125: 211-216, 1993.
32. Burand, J. P., Summers, M. D., and Smith, G. E. Transfection with baculovirus DNA. Virology, 101: 286-290, 1980.
33. Fukasawa, K., Komatani, H., Hara, Y., Suda, H., Okura, A., Nishimura, S., and Yoshinari, T. Sequence-selective DNA cleavage by a topoisomerase I poison, NB-506. Int. J. Cancer, 75: 145-150, 1998.
34. Sugimoto, Y., Tsukahara, S., Oh-hara, T., Liu, L. F., and Tsuruo, T. Elevated expression of DNA topoisomerase II in camplothecin-resistant human tumor cell lines. Cancer Res., 50: 7962-7965, 1990.
35. Chang, J. Y., Dethlefsen, L. A., Barley, L. R., Zhou, B. S., and Cheng, Y. C. Characterization of camptothecin-resistant Chinese hamster lung cells. Biochem. Pharmacol., 43: 2443-2452, 1992.
36. Kanzawa, F., Nishio, K., Kubota, N., and Saijo, N. Antitumor activities of a new indolcarbazole substance, NB-506, and establishment of NB-506-resistant cell lines, SBC-3/NB. Cancer Res., 55: 2806-2813, 1995.
37. Gromova, I. I., Kjeldsen, E., Svejstrup, J. Q., Alsner, J., Christiansen, K., and Westergaard, O. Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I. Nucleic Acids Res., 21: 593-600, 1993.
38. Woessner, R. D., Eng, W. K., Hofmann, G. A., Rieman, D J., McCabe, F. L., Hertzberg, R. P., Mattern, M. R., Tan, K. B., and Johnson, R. K. Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content. Oncol. Res., 4: 481-488, 1992.
39. Beidler, D. R., Chang, J. Y., Zhou, B. S., and Cheng, Y. C. Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines. Cancer Res., 56: 345-353, 1996.
40. Bullock, P., Champoux, J. J., and Botchan, M. Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination. Science (Washington DC), 230: 954-958, 1985.
41. Christiansen, K., and Westergaard, O. Characterization of intra-and intermolecular DNA ligation mediated by eukaryotic topoisomerase I. Role of bipartite DNA interaction in the ligation process. J. Biol. Chem., 269: 721-729, 1994.
42. Pourquier, P., Pilon, A. A., Kohlhagen, G., Mazumder, A., Sharma, A., and Pommier, Y. Trapping of mammalian topoisomerase I and recombination induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J. Biol. Chem., 272: 26441-26447, 1997.
43. Zhu, J., and Schiestl, R. H. Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae. Mol. Cell. Biol., 16: 1805-1812, 1996.
44. Degrassi, F., De Salvia, R., Tanzarella, C., and Palitti, F. Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I. Mutat. Res., 211: 125-130, 1989.